Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (221-230 of 505) with videos related to

Pageof 51
Sort By:
The Journal of Allergy and Clinical Immunology|January 24, 2021
Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analysesAlberto Papi, Johann Christian Virchow, Dave Singh, et al.
Respiratory Medicine|May 5, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS studyDave Singh, Klaus F Rabe, Fernando J Martinez, et al.
NPJ Primary Care Respiratory Medicine|December 20, 2022
Addressing sex and gender to improve asthma managementLouis-Philippe Boulet, Kim L Lavoie, Chantal Raherison-Semjen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 3, 2025
In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory ImagingDave Singh, Nicolas Roche, Libo Wu, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPDDave Singh, Alvar Agustí, Jean Bourbeau, et al.
British Journal of Clinical Pharmacology|May 30, 2008
The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmaticsDave Singh, Jennifer Fairwood, Robert Murdoch, et al.
American Journal of Respiratory and Critical Care Medicine|August 25, 2007
Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthmaDave Singh, Duncan Richards, Richard G Knowles, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 25, 2020
P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cellsSimon Lea, Jian Li, Jonathan Plumb, et al.
Advances in Therapy|July 12, 2023
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma ManagementPeter Daley-Yates, Dave Singh, Juan M Igea, et al.
ERJ Open Research|August 4, 2022
Differential responses of COPD macrophages to respiratory bacterial pathogensSimon Lea, Augusta Beech, James Baker, et al.
Pageof 51

Showing results (221-230 of 505) with videos related to

Sort By:
Pageof 51
The Journal of Allergy and Clinical Immunology|January 24, 2021
Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analysesAlberto Papi, Johann Christian Virchow, Dave Singh, et al.
Respiratory Medicine|May 5, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS studyDave Singh, Klaus F Rabe, Fernando J Martinez, et al.
NPJ Primary Care Respiratory Medicine|December 20, 2022
Addressing sex and gender to improve asthma managementLouis-Philippe Boulet, Kim L Lavoie, Chantal Raherison-Semjen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 3, 2025
In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory ImagingDave Singh, Nicolas Roche, Libo Wu, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPDDave Singh, Alvar Agustí, Jean Bourbeau, et al.
British Journal of Clinical Pharmacology|May 30, 2008
The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmaticsDave Singh, Jennifer Fairwood, Robert Murdoch, et al.
American Journal of Respiratory and Critical Care Medicine|August 25, 2007
Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthmaDave Singh, Duncan Richards, Richard G Knowles, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 25, 2020
P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cellsSimon Lea, Jian Li, Jonathan Plumb, et al.
Advances in Therapy|July 12, 2023
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma ManagementPeter Daley-Yates, Dave Singh, Juan M Igea, et al.
ERJ Open Research|August 4, 2022
Differential responses of COPD macrophages to respiratory bacterial pathogensSimon Lea, Augusta Beech, James Baker, et al.
Pageof 51